Shimono Yohei, Zabala Maider, Cho Robert W, Lobo Neethan, Dalerba Piero, Qian Dalong, Diehn Maximilian, Liu Huiping, Panula Sarita P, Chiao Eric, Dirbas Frederick M, Somlo George, Pera Renee A Reijo, Lao Kaiqin, Clarke Michael F
Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, 1050 Arastradero Road, Palo Alto, CA 94304, USA.
Cell. 2009 Aug 7;138(3):592-603. doi: 10.1016/j.cell.2009.07.011.
Human breast tumors contain a breast cancer stem cell (BCSC) population with properties reminiscent of normal stem cells. We found 37 microRNAs that were differentially expressed between human BCSCs and nontumorigenic cancer cells. Three clusters, miR-200c-141, miR-200b-200a-429, and miR-183-96-182 were downregulated in human BCSCs, normal human and murine mammary stem/progenitor cells, and embryonal carcinoma cells. Expression of BMI1, a known regulator of stem cell self-renewal, was modulated by miR-200c. miR-200c inhibited the clonal expansion of breast cancer cells and suppressed the growth of embryonal carcinoma cells in vitro. Most importantly, miR-200c strongly suppressed the ability of normal mammary stem cells to form mammary ducts and tumor formation driven by human BCSCs in vivo. The coordinated downregulation of three microRNA clusters and the similar functional regulation of clonal expansion by miR-200c provide a molecular link that connects BCSCs with normal stem cells.
人类乳腺肿瘤包含一群具有类似正常干细胞特性的乳腺癌干细胞(BCSC)。我们发现37种微小RNA在人类BCSC与非致瘤性癌细胞之间存在差异表达。三个簇,即miR-200c-141、miR-200b-200a-429和miR-183-96-182在人类BCSC、正常人类和小鼠乳腺干/祖细胞以及胚胎癌细胞中表达下调。BMI1是一种已知的干细胞自我更新调节因子,其表达受miR-200c调控。miR-200c在体外抑制乳腺癌细胞的克隆扩增并抑制胚胎癌细胞的生长。最重要的是,miR-200c在体内强烈抑制正常乳腺干细胞形成乳腺导管的能力以及由人类BCSC驱动的肿瘤形成。三个微小RNA簇的协同下调以及miR-200c对克隆扩增的类似功能调节提供了一个将BCSC与正常干细胞联系起来的分子纽带。